Dmitriy Molchanov
Lawyers
Filters
Novo Nordisk acquisition of Neotope Neuroscience
We advised Novo Nordisk on the acquisition
Loews adds GIC as a partner in Altium Packaging
We advised Loews on the sale of a 47% interest in Altium Packaging
Crowdstrike $400 million acquisition of Humio
We are advising Crowdstrike on the acquisition
KPS Capital Partners $2.1 billion acquisition of assets of Garrett Motion
Davis Polk is advising KPS Capital Partners, LP on its acquisition of substantially all of the assets of Garrett Motion Inc. for approximately $2.1 billion. Garrett Motion filed a motion…
Applied Therapeutics, Inc. Initial Public Offering
Davis Polk advised the representatives of the several underwriters in connection with a $40 million initial public offering of common stock of Applied Therapeutics, Inc. Applied…
Davis Polk Advises Marsh & McLennan Companies, Inc. on Its $250 Million Notes Reopening
Davis Polk advised Marsh & McLennan Companies, Inc. in connection with its SEC-registered offering of $250 million aggregate principal amount of its 4.375% senior notes due 2029. The…
Davis Polk Advises Marsh & McLennan Companies, Inc. on Its €1.1 Billion Senior Notes Offering
Davis Polk advised Marsh & McLennan Companies, Inc. (MMC) in connection with its SEC-registered offering of €550 million aggregate principal amount of its 1.349% senior notes due 2026…
Bombardier Inc. $2 Billion High-Yield Senior Notes Offering
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering by Bombardier Inc. of $2 billion aggregate principal amount of 7.875%…
Davis Polk Advises Marsh & McLennan Companies on Its $5 Billion Senior Notes Offering
Davis Polk advised Marsh & McLennan Companies, Inc. in connection with its SEC-registered offering of $5 billion aggregate principal amount of its $700 million aggregate principal…